Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
India · Delayed Price · Currency is INR 1,111.80
-2.00 (-0.18%)
Jul 24, 2026, 3:30 PM IST
Zydus Lifesciences Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 50,400 | 45,255 | 38,595 | 19,603 | 44,873 |
Depreciation & Amortization | 13,705 | 8,868 | 7,345 | 6,965 | 7,086 |
Other Amortization | 375 | 290 | 296 | 262 | 275 |
Loss (Gain) From Sale of Assets | -23 | -345 | -169 | -208 | -1,110 |
Asset Writedown & Restructuring Costs | - | 2,196 | 177 | 6,042 | - |
Loss (Gain) From Sale of Investments | -292 | -650 | -409 | -483 | -751 |
Provision & Write-off of Bad Debts | 325 | 299 | 206 | 17 | 41 |
Other Operating Activities | -17,087 | -3,461 | -5,343 | -2,882 | -25,229 |
Change in Accounts Receivable | -8,581 | 11,957 | -7,472 | -8,485 | -1,817 |
Change in Inventory | -4,124 | -4,449 | -20 | 4,407 | -5,255 |
Change in Accounts Payable | -7,951 | 735 | -476 | -1,708 | -1,203 |
Change in Other Net Operating Assets | -5,581 | 7,116 | -1,059 | 3,428 | 4,915 |
Operating Cash Flow | 21,166 | 67,811 | 31,963 | 26,888 | 21,045 |
Operating Cash Flow Growth | -68.79% | 112.16% | 18.88% | 27.76% | -36.11% |
Capital Expenditures | -33,940 | -16,937 | -9,066 | -10,309 | -12,026 |
Sale of Property, Plant & Equipment | 249 | 514 | 237 | 394 | 354 |
Cash Acquisitions | -58,793 | -3,690 | -7,201 | - | - |
Divestitures | - | - | - | 400 | - |
Sale (Purchase) of Intangibles | - | - | - | - | 1,127 |
Investment in Securities | -11,164 | -50,168 | -18 | 24,113 | -28,633 |
Other Investing Activities | 19,955 | -12,541 | 1,287 | 776 | 29,175 |
Investing Cash Flow | -82,961 | -83,578 | -14,752 | 15,350 | -10,003 |
Short-Term Debt Issued | 11,892 | 24,020 | - | - | 2,907 |
Long-Term Debt Issued | 70,710 | - | 14 | 1,585 | 7,464 |
Total Debt Issued | 82,602 | 24,020 | 14 | 1,585 | 10,371 |
Short-Term Debt Repaid | - | - | -3,102 | -23,064 | - |
Long-Term Debt Repaid | -9,934 | -147 | -827 | -9,960 | -14,221 |
Total Debt Repaid | -9,934 | -147 | -3,929 | -33,024 | -14,221 |
Net Debt Issued (Repaid) | 72,668 | 23,873 | -3,915 | -31,439 | -3,850 |
Repurchase of Common Stock | - | - | -7,250 | -8,632 | - |
Common Dividends Paid | -11,063 | -3,025 | -6,210 | -2,671 | -3,722 |
Other Financing Activities | -3,536 | -895 | -413 | -1,262 | -1,111 |
Financing Cash Flow | 58,069 | 19,953 | -17,788 | -44,004 | -8,683 |
Foreign Exchange Rate Adjustments | 2,108 | -214 | -231 | 66 | 86 |
Miscellaneous Cash Flow Adjustments | 1,902 | 166 | 60 | - | -259 |
Net Cash Flow | 284 | 4,138 | -748 | -1,700 | 2,186 |
Free Cash Flow | -12,774 | 50,874 | 22,897 | 16,579 | 9,019 |
Free Cash Flow Growth | - | 122.19% | 38.11% | 83.82% | -63.03% |
Free Cash Flow Margin | -4.71% | 21.89% | 11.71% | 9.62% | 5.97% |
Free Cash Flow Per Share | -12.70 | 50.56 | 22.63 | 16.32 | 8.81 |
Cash Interest Paid | 3,536 | 895 | 413 | 1,262 | 1,111 |
Cash Income Tax Paid | 15,910 | 18,019 | 12,858 | 5,920 | 6,746 |
Levered Free Cash Flow | -9,062 | 28,617 | 16,057 | 10,611 | 7,540 |
Unlevered Free Cash Flow | -6,780 | 29,201 | 16,332 | 11,395 | 8,255 |
Change in Working Capital | -26,237 | 15,359 | -9,027 | -2,358 | -3,360 |